Finance entity
Coverage clusters in regulation, which accounts for 2 of those 3, with the remainder spread across 1 other category. Of the tracked stories, 1 of 3 also mention Curaleaf, the most common co-covered peer. At 5, the average consequence score sits below the same-window beat average of 6.3.
Last mentioned: Mar 22, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Coverage clusters in regulation, which accounts for 2 of those 3, with the remainder spread across 1 other category. Of the tracked stories, 1 of 3 also mention Curaleaf, the most common co-covered peer. At 5, the average consequence score sits below the same-window beat average of 6.3. The 26-day window averages about 0.8 stories each week. Source depth averages 2.7 original sources per story, versus 2.6 across the same-window beat baseline. Enphase Energy appears in 3 tracked Finance stories published from February 25, 2026 through March 22, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 2145 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Enphase Energy. Shared-story counts are live from our verified record — not editorial picks.
ENPH Deadline
Final day for Enphase Energy investors to move for lead plaintiff status.
PMI Deadline
Final day for Picard Medical investors to move for lead plaintiff status.
PSFE Deadline
Final day for Paysafe investors to move for lead plaintiff status.
Enphase Energy Filing
Pomerantz LLP files a separate class action against Enphase Energy alleging securities fraud.
Secondary Nektar Notice
A follow-up announcement clarifies the class period and lead plaintiff deadline for Nektar investors.
Nektar Litigation Announced
Pomerantz LLP announces the first class action filing against Nektar Therapeutics.
Legal Notices Issued
Faruqi & Faruqi, LLP issues formal reminders for class action deadlines.
Paysafe Earnings
Paysafe reports mixed Q4 2025 results and issues FY26 outlook.
Pomerantz LLP has initiated class action litigation against Nektar Therapeutics and Enphase Energy, alleging securities fraud and misleading statements. These filings highlight a growing trend of legal scrutiny in the biotech and renewable energy sectors as companies navigate volatile market conditions and regulatory shifts.
Faruqi & Faruqi, LLP has issued critical reminders for investors in Paysafe, Picard Medical, and Enphase Energy regarding upcoming lead plaintiff deadlines in April 2026. These legal actions follow periods of financial reporting and market volatility, signaling a tightening of regulatory and investor oversight for these entities.
Market analysts are highlighting green energy and cannabis as key sectors for 2026, driven by regulatory shifts and maturing business models. As interest rates stabilize, these policy-sensitive industries are attracting renewed investor interest as they transition from speculative plays to fundamental value.
Enphase Energy is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
